New research presented at the American Epilepsy Society’s 78th Annual Meeting suggests that angiotensin receptor blockers (ARBs) may be more effective than other antihypertensive medications in reducing the risk of post-stroke epilepsy (PSE). Two observational studies found that patients with hypertension who were treated with ARBs had a lower risk of developing epilepsy, both after a stroke and even in the absence of stroke, compared to those taking ACE inhibitors, calcium channel blockers (CCBs), or beta-blockers (BBs).